2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

被引：0
作者：
Heidenreich, Paul A.
Solis, Penelope
Estes, N. A. Mark, III
Fonarow, Gregg C.
Jurgens, Corrine Y.
Marine, Joseph E.
McManus, David D.
McNamara, Robert L.
Heidenreich, Paul A.
Albert, Nancy M.
Chan, Paul S.
Curtis, Lesley H.
Ferguson, T. Bruce, Jr.
Fonarow, Gregg C.
Gurvitz, Michelle
Ho, P. Michael
Jurgens, Corrine Y.
O'Brien, Sean
Russo, Andrea M.
Thomas, Randal J.
Varosy, Paul D.
机构：
来源：
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2016年 / 9卷 / 04期
关键词：
AHA Scientific Statements; atrial fibrillation; atrial flutter; performance measures; quality measures; quality indicators; CONVERTING-ENZYME-INHIBITORS; MAINTAINING SINUS RHYTHM; RENIN-ANGIOTENSIN SYSTEM; PLACEBO-CONTROLLED TRIAL; VENTRICULAR RATE CONTROL; MYOCARDIAL-INFARCTION; OF-CARDIOLOGY; FOLLOW-UP; PROGNOSTIC-SIGNIFICANCE; ANTICOAGULANT-THERAPY;
D O I：
10.1161/HCQ.0000000000000018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / +
页数：50
相关论文
共 115 条
  • [41] The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk The TRENDS Study
    Glotzer, Taya V.
    Daoud, Emile G.
    Wyse, D. George
    Singer, Daniel E.
    Ezekowitz, Michael D.
    Hilker, Christopher
    Miller, Clayton
    Qi, Dongfeng
    Ziegler, Paul D.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (05) : 474 - 480
  • [42] Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke - Report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST)
    Glotzer, TV
    Hellkamp, AS
    Zimmerman, J
    Sweeney, MO
    Yee, R
    Marinchak, R
    Cook, J
    Paraschos, A
    Love, J
    Radoslovich, G
    Lee, KL
    Lamas, GA
    [J]. CIRCULATION, 2003, 107 (12) : 1614 - 1619
  • [43] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Chang, YC
    Henault, LE
    Selby, JV
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18): : 2370 - 2375
  • [44] HEMODYNAMIC AND NEUROHORMONAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    GOTTLIEB, SS
    DICKSTEIN, K
    FLECK, E
    KOSTIS, J
    LEVINE, TB
    LEJEMTEL, T
    DEKOCK, M
    [J]. CIRCULATION, 1993, 88 (04) : 1602 - 1609
  • [45] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
    Granger, CB
    McMurray, JJV
    Yusuf, S
    Held, P
    Michelson, EL
    Olofsson, B
    Östergren, J
    Pfeffer, MA
    Swedberg, K
    [J]. LANCET, 2003, 362 (9386) : 772 - 776
  • [46] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [47] Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment
    Hariharan, Sudharshan
    Madabushi, Rajanikanth
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 : 119S - 125S
  • [48] Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Haywood, L. Julian
    Ford, Charles E.
    Crow, Richard S.
    Davis, Barry R.
    Massie, Barry M.
    Einhorn, Paula T.
    Williard, Angela
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (22) : 2023 - 2031
  • [49] Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic target
    Healey, JS
    Connolly, SJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (10) : 9G - 14G
  • [50] Thromboembolic and bleeding complications following St. Jude medical valve replacement - Results of the German experience with low-intensity anticoagulation study
    Hering, D
    Piper, C
    Bergemann, R
    Hillenbach, C
    Dahm, A
    Huth, C
    Horstkotte, D
    [J]. CHEST, 2005, 127 (01) : 53 - 59
12345678910